The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3,4-dichloro-N-(2-(((5-hydroxy-4-oxo-4H-pyran-2-yl)methyl)amino)-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)-5-methyl-1H-pyrrole-2-carboxamide ID: ALA5284544
Max Phase: Preclinical
Molecular Formula: C19H18Cl2N4O4S
Molecular Weight: 469.35
Associated Items:
Names and Identifiers Canonical SMILES: Cc1[nH]c(C(=O)N[C@H]2CCc3nc(NCc4cc(=O)c(O)co4)sc3C2)c(Cl)c1Cl
Standard InChI: InChI=1S/C19H18Cl2N4O4S/c1-8-15(20)16(21)17(23-8)18(28)24-9-2-3-11-14(4-9)30-19(25-11)22-6-10-5-12(26)13(27)7-29-10/h5,7,9,23,27H,2-4,6H2,1H3,(H,22,25)(H,24,28)/t9-/m0/s1
Standard InChI Key: MKUONPTVXORDMA-VIFPVBQESA-N
Molfile:
RDKit 2D
30 33 0 0 0 0 0 0 0 0999 V2000
5.6098 -0.0721 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8129 -0.2856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5994 -1.0825 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8025 -1.2960 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.2192 -0.7126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4326 0.0841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2295 0.2976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4431 1.0945 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.4223 -0.9261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8389 -0.3428 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.0421 -0.5563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7464 -1.2833 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0773 -1.2833 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6606 -1.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4575 -1.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6710 -0.8562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0877 -0.2728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2908 -0.4864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4010 -0.0371 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.4679 -0.6427 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6814 0.1541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0980 0.7375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.4783 0.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1456 -0.1171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8129 0.3677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6098 0.1541 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
-4.5580 1.1522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.9705 1.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7332 1.1522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.1456 -0.9421 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 3 1 0
5 4 1 0
6 5 2 0
7 6 1 0
2 7 1 0
7 8 2 0
9 5 1 0
10 9 1 0
11 10 1 0
11 12 2 0
13 12 1 0
14 13 1 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
13 18 2 0
18 19 1 0
19 11 1 0
16 20 1 6
21 20 1 0
21 22 2 0
23 21 1 0
23 24 2 0
24 25 1 0
25 26 1 0
25 27 2 0
27 28 1 0
27 29 1 0
29 23 1 0
24 30 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 469.35Molecular Weight (Monoisotopic): 468.0426AlogP: 3.64#Rotatable Bonds: 5Polar Surface Area: 120.25Molecular Species: NEUTRALHBA: 7HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.88CX Basic pKa: 3.32CX LogP: 2.85CX LogD: 2.84Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.45Np Likeness Score: -1.07
References 1. He M, Fan M, Peng Z, Wang G.. (2021) An overview of hydroxypyranone and hydroxypyridinone as privileged scaffolds for novel drug discovery., 221 [PMID:34023737 ] [10.1016/j.ejmech.2021.113546 ]